These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18612282)

  • 1. Pfizer jettisons Esperion.
    Shaffer C
    Nat Biotechnol; 2008 Jul; 26(7):724-5. PubMed ID: 18612282
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug shortage crisis affects patients and nurses.
    Carter D
    Am J Nurs; 2011 Nov; 111(11):14. PubMed ID: 22030911
    [No Abstract]   [Full Text] [Related]  

  • 4. Mixing drugs. Latest pharma deals unlikely to affect prices: experts.
    Galloro V
    Mod Healthc; 2009 Mar; 39(11):14. PubMed ID: 19415830
    [No Abstract]   [Full Text] [Related]  

  • 5. A better prescription for drug-development financing.
    Kessel M; Frank F
    Nat Biotechnol; 2007 Aug; 25(8):859-66. PubMed ID: 17687358
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitrust enforcement in pharmaceutical industry mergers.
    Balto DA; Mongoven JF
    Food Drug Law J; 1999; 54(3):255-78. PubMed ID: 11797700
    [No Abstract]   [Full Text] [Related]  

  • 7. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 9. Saying no to samples.
    Tsai A
    Med Econ; 2009 Nov; 86(22):22-4, 27. PubMed ID: 20055014
    [No Abstract]   [Full Text] [Related]  

  • 10. GlaxoSmithKline, Pfizer to merge HIV drug units in new company.
    AIDS Read; 2009; 19(6):206. PubMed ID: 19642236
    [No Abstract]   [Full Text] [Related]  

  • 11. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

  • 12. Sugen falls as casualty of Pfizer-Pharmacia merger.
    Garber K
    Nat Biotechnol; 2003 Jul; 21(7):722-3. PubMed ID: 12833079
    [No Abstract]   [Full Text] [Related]  

  • 13. Never again.
    Scott C
    Nat Biotechnol; 2010 Feb; 28(2):131. PubMed ID: 20139946
    [No Abstract]   [Full Text] [Related]  

  • 14. Health care and the pharmaceutical industry.
    Schwartz JB
    J Parenter Sci Technol; 1993; 47(5):191. PubMed ID: 8263657
    [No Abstract]   [Full Text] [Related]  

  • 15. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 16. GSK moves on Sirtris.
    Sipp D
    Nat Biotechnol; 2008 Jun; 26(6):595. PubMed ID: 18536662
    [No Abstract]   [Full Text] [Related]  

  • 17. Amgen becomes a stronger cancer player.
    Kling J
    Nat Biotechnol; 2006 Feb; 24(2):119. PubMed ID: 16465140
    [No Abstract]   [Full Text] [Related]  

  • 18. Exiting this year and into the next.
    Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
    [No Abstract]   [Full Text] [Related]  

  • 19. Deals landscape: notable deals in the pharmaceutical industry in the second quarter of 2008.
    Bright J; Lakeram M
    IDrugs; 2008 Aug; 11(8):584-91. PubMed ID: 18724496
    [No Abstract]   [Full Text] [Related]  

  • 20. Merv Turner.
    Turner M
    Nat Biotechnol; 2011 Mar; 29(3):186. PubMed ID: 21390005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.